PharmInvent's CEO Presenting for ECPM - Clinical and Safety Data Evaluation and Biostatistics
Aug 29, 2016
We are happy to annouce that PharmInvent‘s CEO Dr. Jan Petracek will be teaching at the European Center for Pharmaceutical Medicine‘s training course on September 5, 2016 in Basel, Switzerland.
The training course makes up the 4th of a multi-module overall training program and will cover in detail the topic of Clinical and Safety Data Evaluation and Biostatistics.
Dr. Petracek’s vast working knowledge, expertise and ongoing experience with EU ADR Reporting Eudravigilance will be the topic of his training.
The training course involves topics ranging from:
- Statistical Concepts in the Prospective Planning and Design of the Successful Outcome of a Clinical Trial
- Planning and Performing a Phase III Trial
- Working with CRO’s and Patient Safety
- Missing Data in Clinical Trials
- Plus more
The training course also includes three separate case studies with question and answer sessions.
For more details on the European Center for Pharmaceutical Medicine, please visit their site here:
To learn more about having Dr. Jan Petracek conduct a private corporate training on this topic or other pharmacovigilance related topics, please contact us here.